Expertise in
8
conditions

Roberto Crocchiolo

Milan, IT 
Expertise in
8
conditions
Milan, IT 

Overview

Roberto Crocchiolo practices practicing medicine in Milan, Italy.

Mr. Crocchiolo is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Bone Marrow Transplant, and Bone Graft.

He is actively involved in clinical research, co-authoring 119 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Milan, Italy
Other Locations
Gruppo, Italy
Treviglio, Italy
Via Manzoni 56, Rozzano, 20089, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Drug
Study Drug: High-Dose Sequential Chemotherapy and Autologous Transplant
Study Phase: Phase 2
A Phase II Trial to Evaluate the Safety and Activity of Single-agent Lenalidomide Given as Maintenance Therapy After Response to Second-line Therapy in Patients With Relapsed DLBCL, Not Eligible for High-dose Chemotherapy and ASCT (Autologous Stem-Cell Transplantation)
A Phase II Trial to Evaluate the Safety and Activity of Single-agent Lenalidomide Given as Maintenance Therapy After Response to Second-line Therapy in Patients With Relapsed DLBCL, Not Eligible for High-dose Chemotherapy and ASCT (Autologous Stem-Cell Transplantation)
Enrollment Status: Completed
Publish Date: April 10, 2024
Intervention Type: Drug
Study Drug: Lenalidomide
Study Phase: Phase 2
View 1 Less Clinical Trial

119 Total Publications

Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects.
Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects.
Journal: Transplant immunology
Published: May 13, 2026

Frequently Asked Questions about Roberto Crocchiolo

Is Roberto Crocchiolo a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Roberto Crocchiolo is classified as an Elite expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Roberto Crocchiolo participate in research or clinical trials?

Yes. Roberto Crocchiolo has published 119 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Roberto Crocchiolo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Crocchiolo's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile